Controversial weight loss drug hitting shelves
TEXT OF STORY
SCOTT JAGOW: Tomorrow, drugmaker Glaxo launches an over-the-counter weight loss pill called Alli. With so many Americans overweight, this could be a blockbuster drug. But it has plenty of critics, Helen Palmer reports from our Health Desk at WGBH.
Helen Palmer: Glaxo’s spending $150 million to market Alli, a half-strength version of prescription weight-loss pill Xenical
. But critics say it should not be available without a prescription. Alex Sugerman-Brozan of the consumer watchdog Prescription Access Litigation Project:
Alex Sugerman-Brozan: There is nothing to prevent people who should not be using this drug from using it — particularly teenagers and people with eating disorders for whom this drug could be quite dangerous.
Sugerman-Brozan says Alli’s only approved for adults, but there’s no mechanism to control who actually buys the drug.
Glaxo insists pharmacists won’t sell it to teenagers, and they’ve produced a book full of advice called “Losing Weight Without Losing Your Mind,” and an extensive website. But Sugerman-Brozan says that won’t stop abuse.
Sugerman-Brozan: This is not aspirin. It’s a very strong drug with very significant effects.
He says Alli works by preventing the digestion of fat. It blocks vital fat soluble vitamins like A, E and D and poses a danger of malnutrition.
In Boston, I’m Helen Palmer for Marketplace.
There’s a lot happening in the world. Through it all, Marketplace is here for you.
You rely on Marketplace to break down the world’s events and tell you how it affects you in a fact-based, approachable way. We rely on your financial support to keep making that possible.
Your donation today powers the independent journalism that you rely on. For just $5/month, you can help sustain Marketplace so we can keep reporting on the things that matter to you.
